Don't want ads? Subscribe or login now.

IRS Finalizes Anti-Inversion Regs That Sank $160B Pfizer Deal

By Vidya Kauri · July 11, 2018, 6:49 PM EDT

The Internal Revenue Service implemented regulations Wednesday that a federal court had invalidated last October after they sank a planned $160 billion merger between Pfizer Inc. and Allergan PLC of Ireland....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Regulations

Recent Articles By Vidya

June 21, 2019
Private Cos. Face Higher Costs In Tax Disclosure Proposals
June 18, 2019
IRS Aims To Fix Error Slanting Farm Sales Toward Co-Ops
June 14, 2019
A New Tax Strategy For Multinationals: Shunning Tax Havens
June 11, 2019
No Tax On $4M Gain For Greek Mining Co., DC Circ. Affirms
June 07, 2019
9th Circ. Again Revives IRS Cost-Sharing Rule In Altera Row
May 24, 2019
DC Circ. Denies $33M Deduction For Land Gift To U Of Mich.
May 22, 2019
Executive Privilege A Poor Shield For Trump's Tax Docs
May 17, 2019
High Court Plea Could Undermine Tax Laws Lacking Regs
May 15, 2019
10th Circ. Denies Deductions For Benefit Plan Expenses
May 13, 2019
Attys Back Biz Owner's High Court Plea To Refuse Subpoenas

IRS Finalizes Anti-Inversion Regs That Sank $160B Pfizer Deal

Documents

Related Sections

Recent Articles By Vidya